Long-term treatment of uterine fibroids with ulipristal acetate ☆
about
Long-term intermittent pharmacological therapy of uterine fibroids - a possibility to avoid hysterectomy and its negative consequencesThe clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroidsUlipristal acetate for fibroidsSelective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.Successful pregnancy after treatment with ulipristal acetate for uterine fibroidsUlipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.Role of nuclear progesterone receptor isoforms in uterine pathophysiology.The conservative and interventional treatment of fibroidsPresentation and treatment of uterine leiomyoma in adolescence: a systematic review.Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.Expulsion of a uterine myoma in a patient treated with ulipristal acetate.Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.Safety after extended repeated use of ulipristal acetate for uterine fibroidsEndocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapiesUterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.An update on the pharmacological management of adenomyosis.Selective progesterone receptor modulators: a class with multiple actions and applications in reproductive endocrinology, and gynecology.Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis.The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.An observation study of the clinical evaluation of symptom relief and side effects associated with taking ulipristal acetate (esmya) including its effect on pre-menstrual syndrome.Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Selective progesterone receptor modulators (SPRMs) for uterine fibroids.Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology.Uterine fibroid management: from the present to the future.Choice of primary outcomes evaluating treatment for heavy menstrual bleeding.Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis.Molecular and clinical attributes of uterine leiomyomas.Updated approaches for management of uterine fibroidsEconomic impact of ulipristal acetate on surgical procedures for uterine fibroids in FranceSelective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.Uterine fibroids - what's new?Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries.Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis.
P2860
Q26751927-81188C44-92F9-4E55-A67B-A199DB1B41FAQ26998672-9D38009F-14C3-472A-92DB-6A572110E5E1Q28080041-E7E7ABA3-4D7C-4C7C-A1CA-37983A1DD1AFQ33589684-C42FC34F-AB38-4CC1-A6A6-1ECBB1536317Q34038083-40EF77B1-7186-4DE2-A349-E13C238E5D72Q34447552-F1A44F68-5EFF-4D01-A45C-FA3CEE2ED3C2Q34448400-FA659218-58B3-4F55-B63E-71E865872258Q34982023-177508EB-5C1D-4860-B201-741DB8390A84Q35021066-5F8FFDAA-B5AE-4585-929E-0F5E994CA888Q35240186-480A06E4-8901-46B9-9609-4FE9CB84C316Q35512180-90A12AE8-C4D9-4D54-B48C-E763D7D75C97Q35573858-1A0660FD-E69D-4B81-BA62-E3FB6DCF0E60Q35617315-B111E3B1-63A0-4E65-AAC8-8EFEA09CB697Q35810608-4EA20F96-453C-42A3-AF37-1A0482ED0C79Q35969254-716608FA-7A1B-47F0-AAB3-AF4EA7A0F863Q36299562-9BAA66D9-A604-413B-95D9-09FB6971CBBCQ36525065-AE96B276-B392-42BD-B07C-2DEE93BF25A6Q37186618-63E589B2-FA05-4D37-8155-0A185BA16AF4Q37647346-CF0A3703-A828-4303-A842-4742A71918DDQ38246723-D34DBAA1-4E1E-4BDF-9EF5-ED9D9BCA1186Q38252992-B047C14E-9A28-4317-9909-FA7323EDC59FQ38378813-1F80D53B-67CC-46FC-8590-995869A933D7Q38634268-749B9E10-0255-4672-AE6B-20ED253DE5D0Q38676367-AB797FC6-8F35-4B95-A395-82616A097B32Q38789764-361F228E-1BA2-4124-BCDB-568464558575Q38792320-259CBBCB-7791-4D3F-9188-3B7447274D73Q38819001-B15B4472-41BA-4214-B076-453D6F101210Q38831211-59DC3D31-FD08-4A05-A6E8-C71931EB7896Q38837038-CEE223B4-BF31-4AB8-BE68-2D9EDC27C69AQ38848136-BD989B48-84E4-4AFE-8A5B-28C157DD4714Q38980489-53F318F7-F098-420A-B458-7A6B48A1779EQ39080721-17171881-C05F-43FD-A63B-53F1BC72B85BQ39244598-B29C74A8-CA1C-4367-B3CF-C527D4458E93Q39400414-5BEF573C-F2D7-4AA5-9302-611394E0E417Q41385417-A96B8FDC-6F08-468B-AAC6-A4BD7ABADE5AQ41581866-2CB185CB-83FF-4D59-826F-52F119827577Q46560230-20B8FC1E-0679-4BDE-B1B9-366949234345Q47135445-AEF8A0CC-87B5-449A-9AFD-5CF69C4D18CBQ47136481-C44ACCFA-55FF-406C-8DA8-3BBBB04A23EDQ47160345-C69C103C-29C8-4AB6-9FBD-B4B2F2ADB5F4
P2860
Long-term treatment of uterine fibroids with ulipristal acetate ☆
description
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2014
@ast
im Juni 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2014)
@en
vedecký článok (publikovaný 2014-06)
@sk
vědecký článek publikovaný v roce 2014
@cs
wetenschappelijk artikel (gepubliceerd in 2014-06)
@nl
наукова стаття, опублікована в червні 2014
@uk
مقالة علمية (نشرت في يونيو 2014)
@ar
name
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@ast
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@en
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@nl
type
label
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@ast
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@en
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@nl
prefLabel
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@ast
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@en
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@nl
P2093
P3181
P1476
Long-term treatment of uterine fibroids with ulipristal acetate ☆
@en
P2093
Bart C J M Fauser
David H Barlow
Elke Bestel
Ernest Loumaye
Francisco Vázquez
Ian Osterloh
Janusz Tomaszewski
Kazem Nouri
Olivier Donnez
Philippe Bouchard
P304
1565-73.e1-18
P3181
P356
10.1016/J.FERTNSTERT.2014.02.008
P407
P577
2014-06-01T00:00:00Z